Back to search results

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Maryanne Odinakachukwu) · modinakach@childrensnational.org · 202-476-2957
    Contact: Principal Investigator (Robert Nickel)
    David Jacobsohn (Sub-investigator)
    Anant Vatsayan (Sub-investigator)
    Blachy Dávila-Saldaña (Sub-investigator)
    Evelio Perez-Albuerne (Sub-investigator)
    Catherine Bollard (Sub-investigator)
Study leads

  • Robert Nickel, MD

    Principal Investigator

    Children's National Research Institute

View source on ClinicalTrials.gov(opens in a new tab)